Your browser doesn't support javascript.
loading
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial.
Lee, Jung-Yun; Kim, Byoung-Gie; Kim, Jae-Weon; Lee, Jung Bok; Park, Eunhyang; Joung, Je-Gun; Kim, Sunghoon; Choi, Chel Hun; Kim, Hee Seung.
Afiliação
  • Lee JY; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea. jungyunlee@yuhs.ac.
  • Kim BG; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
  • Kim JW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
  • Lee JB; Department of Clinical Epidemiology & Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Ulsan, Korea.
  • Park E; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
  • Joung JG; Department of Biomedical Science, College of Life Science, CHA University, Seongnam, Korea.
  • Kim S; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea.
  • Choi CH; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
  • Kim HS; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
J Gynecol Oncol ; 33(4): e45, 2022 07.
Article em En | MEDLINE | ID: mdl-35320892
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antígeno B7-H1 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: J Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article País de publicação:
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antígeno B7-H1 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: J Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article País de publicação: